quality of care

Research in Review

Adjuvant Chemo After Surgery Improves OS in Patients With NSCLC and Brain Metastasis

06/03/2017

JCP Editors

Patients with non-small cell lung cancer (NSCLC) and synchronous brain metastasis demonstrate improved 1-year and 5-year overall survival (OS) after thoracic surgery and systemic chemotherapy, according to research...

...

06/03/2017

Journal of Clinical Pathways

Research in Review

Financial Benefit of NGS Varies by Patient, Disease Type in Community Settings

06/01/2017

JCP Editors

Next-generation sequencing (NGS) may be economically beneficial for select patients with treated in the community oncology setting, but it should be carefully applied due to potential associated financial burdens,...

...

06/01/2017

Journal of Clinical Pathways

Research in Review

Microbiome Signature Helps Predict Prostate Cancer

06/01/2017

JCP Editors

Transcriptome sequencing that identifies pathogens in prostate cancer biopsies can be used as a signature for disease detection, according to research presented at the 2017 ASCO Annual Meeting (June 2-6, 2017;...

...

06/01/2017

Journal of Clinical Pathways

Research in Review

B-Cell Malignancy Provides Economic Burden to US Commercial Payers

05/30/2017

JCP Editors

The high economic burden of B-cell malignancies on US commercial insurers may impact future reimbursement decisions, according to research that will be presented at the 2017 ASCO Annual Meeting (June 2-6, 2017;...

The...

05/30/2017

Journal of Clinical Pathways

Research in Review

HPV Vaccine Underutilized Despite Significant Oral HPV Infection Protection

05/30/2017

JCP Editors

Research presented at the 2017 American Society of Clinical Oncology showed that although human papillomavirus (HPV) vaccine reduces the rate of oral HPV infection, the vaccine is still underutilized among teens and...

...

05/30/2017

Journal of Clinical Pathways

Research in Review

Aggressive Care Associated With Poorer Outcomes for Patients With NSCLC at End-of-Life

05/26/2017

JCP Editors

Aggressive care within the last month of life for patients with non-small cell lung cancer (NSCLC) is associated with lower family evaluations of end-of-life care, according to new research. ----- Related...

...

05/26/2017

Journal of Clinical Pathways

Research in Review

Targeted Therapy May Improve Outcomes for Patients With Multiple Myeloma

05/22/2017

JCP Editors

Targeted therapy against a particular protein has the potential to improve outcomes and fracture-free survival for patients with multiple myeloma, according to research that will be presented at the 2017 ASCO...

...

05/22/2017

Journal of Clinical Pathways

Research in Review

Trastuzumab Emtansine Improves OS in Patients With HER2+ Breast Cancer

05/19/2017

JCP Editors

Patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer benefit from an estimated 7 additional months of survival if treated with trastuzumab emtansine rather than the physician’s choice...

...

05/19/2017

Journal of Clinical Pathways

Research in Review

Chemotherapy After Surgery Improves Survival in Biliary Tract Cancer

05/18/2017

JCP Editors

Administering capecitabine after surgery extends survival by a median of 17 months compared with surgery alone for patients with biliary tract cancer, according to research that will be presented at the 2017 ASCO...

...

05/18/2017

Journal of Clinical Pathways

Research in Review

Targeted Therapy Improves Disease-Free Survival in Intermediate-Risk NSCLC

05/18/2017

JCP Editors

Adjuvant treatment with the targeted therapy gefitinib (Iressa, AstraZeneca) significantly improved disease-free survival (DFS) over standard of care after surgery for patients with non–small cell lung cancer...

...

05/18/2017

Journal of Clinical Pathways